Edit search
Further clinical and molecular delineation of the 9q subtelo…
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.
Article, Chapter
Authors: T. Kleefstra
Publication: Journal of Medical Genetics, Volume:46, Issue:9, Page(s):598-606
Published: BMJ Group, 2009
ISSN: 0022-2593
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item